243 related articles for article (PubMed ID: 35347439)
1. Development and comparison of three
Hu G; Zhu W; Liu Y; Wang Y; Zhang Z; Zhu S; Duan W; Zhou P; Fu C; Li F; Huo L
Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2634-2644. PubMed ID: 35347439
[TBL] [Abstract][Full Text] [Related]
2. Development of a Humanized VHH Based Recombinant Antibody Targeting Claudin 18.2 Positive Cancers.
Zhong W; Lu Y; Ma Z; He Y; Ding Y; Yao G; Zhou Z; Dong J; Fang Y; Jiang W; Wang W; Huang Y
Front Immunol; 2022; 13():885424. PubMed ID: 35837391
[TBL] [Abstract][Full Text] [Related]
3. Screening and Preclinical Evaluation of Novel Radiolabeled Anti-Fibroblast Activation Protein-α Recombinant Antibodies.
Xu J; Li S; Xu S; Dai J; Luo Z; Cui J; Cai F; Geng C; Wang Z; Tang X
Cancer Biother Radiopharm; 2023 Dec; 38(10):726-737. PubMed ID: 35612467
[No Abstract] [Full Text] [Related]
4. Development of a CLDN18.2-targeting immuno-PET probe for non-invasive imaging in gastrointestinal tumors.
Chen Y; Hou X; Li D; Ding J; Liu J; Wang Z; Teng F; Li H; Zhang F; Gu Y; Yu S; Qian X; Yang Z; Zhu H
J Pharm Anal; 2023 Apr; 13(4):367-375. PubMed ID: 37181294
[TBL] [Abstract][Full Text] [Related]
5. In Vitro and In Vivo Characterization of
Allen KJH; Jiao R; Li J; Beckford-Vera DR; Dadachova E
Molecules; 2022 Oct; 27(19):. PubMed ID: 36235126
[No Abstract] [Full Text] [Related]
6.
Qi C; Guo R; Chen Y; Li C; Liu C; Zhang M; Zhang C; Zhang X; Hou X; Chen B; Jia B; Yang Z; Shen L; Zhu H
J Nucl Med; 2024 Jun; 65(6):856-863. PubMed ID: 38604764
[No Abstract] [Full Text] [Related]
7. Light-Induced Radiosynthesis of
Klingler S; Fay R; Holland JP
J Nucl Med; 2020 Jul; 61(7):1072-1078. PubMed ID: 31924725
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and Biodistribution of
Ghosh S; Fletcher NL; Huda P; Houston ZH; Howard CB; Lund ME; Lu Y; Campbell DH; Walsh BJ; Thurecht KJ
Mol Pharm; 2023 Mar; 20(3):1549-1563. PubMed ID: 36602058
[TBL] [Abstract][Full Text] [Related]
9.
Price EW; Carnazza KE; Carlin SD; Cho A; Edwards KJ; Sevak KK; Glaser JM; de Stanchina E; Janjigian YY; Lewis JS
J Nucl Med; 2017 Sep; 58(9):1386-1394. PubMed ID: 28280216
[TBL] [Abstract][Full Text] [Related]
10. MicroPET imaging of integrin αvβ3 expressing tumors using 89Zr-RGD peptides.
Jacobson O; Zhu L; Niu G; Weiss ID; Szajek LP; Ma Y; Sun X; Yan Y; Kiesewetter DO; Liu S; Chen X
Mol Imaging Biol; 2011 Dec; 13(6):1224-33. PubMed ID: 21161690
[TBL] [Abstract][Full Text] [Related]
11. Site-specifically labeled
Kristensen LK; Christensen C; Jensen MM; Agnew BJ; Schjöth-Frydendahl C; Kjaer A; Nielsen CH
Theranostics; 2019; 9(15):4409-4420. PubMed ID: 31285769
[TBL] [Abstract][Full Text] [Related]
12. Fusion of hIgG1-Fc to 111In-anti-amyloid single domain antibody fragment VHH-pa2H prolongs blood residential time in APP/PS1 mice but does not increase brain uptake.
Rotman M; Welling MM; van den Boogaard ML; Moursel LG; van der Graaf LM; van Buchem MA; van der Maarel SM; van der Weerd L
Nucl Med Biol; 2015 Aug; 42(8):695-702. PubMed ID: 25960433
[TBL] [Abstract][Full Text] [Related]
13. Human Epidermal Growth Factor Receptor 3-Specific Tumor Uptake and Biodistribution of
Warnders FJ; Terwisscha van Scheltinga AGT; Knuehl C; van Roy M; de Vries EFJ; Kosterink JGW; de Vries EGE; Lub-de Hooge MN
J Nucl Med; 2017 Aug; 58(8):1210-1215. PubMed ID: 28360206
[TBL] [Abstract][Full Text] [Related]
14. Preclinical Evaluation of an Engineered Single-Chain Fragment Variable-Fragment Crystallizable Targeting Human CD44.
Diebolder P; Mpoy C; Scott J; Huynh TT; Fields R; Spitzer D; Bandara N; Rogers BE
J Nucl Med; 2021 Jan; 62(1):137-143. PubMed ID: 32513906
[TBL] [Abstract][Full Text] [Related]
15. Development of a Chimeric Antigen-Binding Fragment Directed Against Human Galectin-3 and Validation as an Immuno-Positron Emission Tomography Tracer for the Sensitive
Peplau E; De Rose F; Reder S; Mittelhäuser M; Scafetta G; Schwaiger M; Weber WA; Bartolazzi A; Skerra A; D'Alessandria C
Thyroid; 2020 Sep; 30(9):1314-1326. PubMed ID: 32200708
[No Abstract] [Full Text] [Related]
16. First-in-human CLDN18.2 functional diagnostic pet imaging of digestive system neoplasms enables whole-body target mapping and lesion detection.
Wang S; Qi C; Ding J; Li D; Zhang M; Ji C; Jiang F; Teng F; Yu J; Qian X; Wang F; Shen L; Gao J; Yang Z; Zhang C; Zhu H
Eur J Nucl Med Mol Imaging; 2023 Jul; 50(9):2802-2817. PubMed ID: 37099132
[TBL] [Abstract][Full Text] [Related]
17. ImmunoPET imaging of tissue factor expression in pancreatic cancer with
Hernandez R; England CG; Yang Y; Valdovinos HF; Liu B; Wong HC; Barnhart TE; Cai W
J Control Release; 2017 Oct; 264():160-168. PubMed ID: 28843831
[TBL] [Abstract][Full Text] [Related]
18. Quantitative PET imaging of Met-expressing human cancer xenografts with 89Zr-labelled monoclonal antibody DN30.
Perk LR; Stigter-van Walsum M; Visser GW; Kloet RW; Vosjan MJ; Leemans CR; Giaccone G; Albano R; Comoglio PM; van Dongen GA
Eur J Nucl Med Mol Imaging; 2008 Oct; 35(10):1857-67. PubMed ID: 18491091
[TBL] [Abstract][Full Text] [Related]
19. Exploration of radionuclide labeling of a novel scFv-Fc fusion protein targeting CLDN18.2 for tumor diagnosis and treatment.
Li D; Ding L; Chen Y; Wang Z; Zeng Z; Ma X; Huang H; Li H; Qian X; Yang Z; Zhu H
Eur J Med Chem; 2024 Feb; 266():116134. PubMed ID: 38266552
[TBL] [Abstract][Full Text] [Related]
20. Novel VHH-Based Tracers with Variable Plasma Half-Lives for Imaging of CAIX-Expressing Hypoxic Tumor Cells.
van Lith SAM; Huizing FJ; Franssen GM; Hoeben BAW; Lok J; Doulkeridou S; Boerman OC; Gotthardt M; van Bergen En Henegouwen PMP; Bussink J; Heskamp S
Mol Pharm; 2022 Oct; 19(10):3511-3520. PubMed ID: 35044182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
